🔗 Share this article

This year's prestigious award in medical science was awarded for transformative discoveries that illuminate how the body's defense network targets dangerous pathogens while sparing the healthy tissues.

A trio of renowned scientists—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this accolade.

The work identified specialized "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the body.

The discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.

These winners will share a prize fund valued at 11 million SEK.

Crucial Findings

"The research has been decisive for comprehending how the immune system operates and the reason we do not all develop serious self-attack conditions," commented the head of the Nobel Committee.

This trio's studies explain a core question: In what way does the defense system defend us from countless invaders while leaving our own tissues intact?

The body's protection system uses immune cells that search for signs of disease, including pathogens and germs it has never encountered.

These cells utilize sensors—known as recognition units—that are generated randomly in countless variations.

That provides the defense network the ability to combat a wide array of threats, but the randomness of the mechanism inevitably creates immune cells that may attack the body.

Security Guards of the Immune System

Researchers previously knew that a portion of these problematic defense cells were destroyed in the immune organ—where immune cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the body to neutralize other defenders that assault the body's own tissues.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These findings have established a novel area of investigation and accelerated the development of innovative treatments, for instance for cancer and immune disorders."

In malignancies, regulatory T-cells prevent the system from fighting the tumor, so research are focused on lowering their quantity.

In self-attack disorders, experiments are exploring increasing T-reg cells so the body is not under attack. A comparable approach could also be useful in reducing the chances of organ transplant failure.

Innovative Experiments

Professor Sakaguchi, from Osaka University, conducted tests on rodents that had their thymus extracted, leading to autoimmune disease.

The researcher demonstrated that injecting defense cells from healthy mice could prevent the illness—implying there was a mechanism for preventing defenders from attacking the host.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited immune disorder in rodents and people that resulted in the discovery of a gene critical for how T-regs operate.

"The groundbreaking research has uncovered how the immune system is kept in check by regulatory T cells, stopping it from accidentally attacking the healthy cells," commented a prominent physiology expert.

"This research is a remarkable example of how fundamental physiological research can have far-reaching implications for human health."